Nabiey Romin 4

What Happened

• Nabiey Romin, Chief Accounting Officer of GoodRx (GDRX), had restricted stock units convert into 12,434 shares on March 8, 2026 (transaction code M). To satisfy tax withholding, 5,121 of those shares were withheld (transaction code F) at $2.28 per share, generating $11,676 in consideration. The insider received a net 7,313 shares (12,434 acquired − 5,121 withheld).
• This was not an open‑market sale; the withheld shares appear to be a routine tax withholding related to vesting/conversion of equity awards rather than a discretionary sale.

Key Details

• Transaction date: March 8, 2026; Form 4 filed March 9, 2026 (appears timely).
• Acquired (M): 10,201 shares and 2,233 shares = 12,434 total shares converted.
• Withheld for taxes (F): 4,201 shares and 920 shares = 5,121 shares at $2.28/share, total proceeds $11,676.
• Net shares delivered to insider: 7,313.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes: F1—each restricted stock unit (RSU) equals one share; F2 & F3—describe vesting schedules (initial 6.25% cliff vest then remaining 93.75% vest in roughly equal quarterly installments over 15 quarters).
• Transaction codes: M = exercise/conversion of derivative (here, RSU conversion); F = payment of exercise price or tax liability (share withholding to cover taxes).

Context

• This appears to be a standard RSU vest/conversion with shares withheld to cover tax obligations (a common cash‑less withholding method), not an open‑market sale that would signal a liquidity event.
• Such withholding transactions are routine for employees receiving equity awards and do not, by themselves, indicate insider sentiment about the company’s stock.